European Union International Standa... NGOs United Nations
Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua & Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia & Herzegovina Botswana Bouvet Island Brazil British Indian Ocean... British Virgin Islands Brunei Bulgaria Burkina Faso Burma (Myanmar) Burundi Cambodia Cameroon Canada Cape Verde Islands Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo (Brazzaville) Congo, Democratic Re... Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Terr... Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Hawai Heard and McDonald I... Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Northern Marianas Islands Norway Oman Pakistan Palau Palestinian Authority Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Island Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Samoa San Marino Sao Tome & Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia South Korea Spain Sri Lanka St-Barthelemy St-Martin St. Helena St. Kitts & Nevis St. Lucia St. Pierre et Miquelon St. Vincent & the Gr... Sudan Suriname Svalbard & Jan Mayen... Swaziland Sweden Switzerland Syria Taiwan (Republic of ... Tajikistan Tanzania Thailand Togo Tokelau Tonga Trinidad & Tobago Tunisia Turkey Turkmenistan Turks & Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States (Minor... United States of America Uruguay US Virgin Islands Uzbekistan Vanuatu Vatican City State (... Venezuela Vietnam Wallis & Futuna Islands Western Sahara Yemen Zambia Zimbabwe
|
Scientific Committee on Consumer Products (SCCP)
Report Title: |
Preliminary Opinion on Safety of Nanomaterials in Cosmetic Products |
Report ID: |
191 |
Date: |
6/19/2007 |
Author: |
Scientific Committee on Consumer Products (SCCP) |
Report Type: |
Committee Report |
URL: |
[sccp_o_099.pdf] |
Country: |
European Union |
Organization: |
Scientific Committee on Consumer Products (SCCP) |
Summary: |
Following a report by the UK Royal Society and Royal Academy of Engineering which suggested treating nanomaterials as new chemicals and questioned the suitability of mass-based standards for assessing toxicological risks, the European Communitys Scientific Committee on Consumer Products (SCCP) was requested to examine the safety of nanomaterials in cosmetic products. These materials are either labile (disintegrating upon skin contact into their molecular components) or insoluble (such as titanium dioxide in sunscreen). Insoluble nanoparticles are the primary cause of concern for human safety. This committee report examines possible health concerns and exposure routes of these nanoparticles. The existing in vitro technique for estimating skin absorption may not be applicable to nanoscale materials, and the committee suggests that new methodologies are needed. One major problem is the need for in vivo testing to determine nanoparticle concentrations in organs, because of the ban upon animal testing for cosmetic products. |
Archived Copy: |
SCCP (2007), Preliminary opinion on safety of nano_191_8431.pdf |
|
|
Report Title: |
The SCCP'S Notes of Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation, 6th Revision |
Report ID: |
164 |
Date: |
12/19/2006 |
Author: |
European Union, Scientific Committee on Consumer Products |
Report Type: |
Guidance Document |
URL: |
[sccp_o_03j.pdf] |
Country: |
European Union |
Organization: |
Scientific Committee on Consumer Products (SCCP) |
Summary: |
The document contains relevant information on the different aspects of testing and safety evaluation of cosmetic ingredients. It is designed to provide guidance to public authorities and cosmetic industry, in order to improve harmonized compliance with Directive 76/768/EEC 1 and in particular by the Sixth (Dir. 93/35/EEC) and Seventh (Dir. 2003/15/EC3) Amendments to this Directive. The "Notes of Guidance" are regularly revised and updated in order to incorporate the progress of scientific knowledge in general, and the experience gained in particular, in the field of testing and safety evaluation of cosmetic ingredients. Since the last revision, several new opinions of importance to the content of this guidance document have been adopted and they form the basis of this new revision. The Notes of Guidance should not be seen as a checklist, but have been compiled to provide assistance in the complex process of the testing and safety evaluation of cosmetic ingredients. As was also the case in the previous revision, individual SCCP opinions are not provided in detail, but are briefly summarized and clearly referred to. The revisions contained in this document focus on cosmetic products, with particular emphasis placed on testing guidelines and safety assessments.
|
Archived Copy: |
sccp_o_03j_164_5464.pdf |
|
|
Report Title: |
Preliminary Opinion on Safety of Nanomaterials in Cosmetic Products |
Report ID: |
77 |
Date: |
6/19/2007 |
Report Type: |
General Report |
URL: |
[risk_en.htm] |
Country: |
Other |
Organization: |
Scientific Committee on Consumer Products (SCCP) |
Summary: |
This opinion is a response by the SCCP to questions regarding the safety of nanomatierals in cosmetic products, the implications on animal testing, and whether previous opinions about nanomaterials currently used in sunscreen products would need to be revised. The opinion indicated that conventional risk assessment methodologies may be adequate for labile nanoparticles. However, it mentioned that primary health concerns involve insoluble particles but are inconclusive due to insufficient information at this time. Furthermore, the opinion stresses the need for new methodologies to assess percutaneous penetration pathways because evidence indicates that mechanical and/or chemical action on the skin may have an effect on nanoparticles penetration. This opinion also stated that large data gaps exist in the risk assessment of nanoparticles used in cosmetic products that are inhaled and ingested. In regards to animal testing, the opinion stated that only validated “in vitro” methods may be tested on animals, but currently there are no validated “in vitro” methods for nanomaterials. Finally, the opinion found that due to the considerable increase in available scientific data on nanosized particles it is necessary to review safety of nanomaterials currently used in sunscreen products. |
|
|
|